Kusumoto M - Search Results

1

Phase 1 clinical trial of irradiated autologous melanoma cells adenovirally transduced with human GM-CSF gene.

Kusumoto M, Umeda S, Ikubo A, Aoki Y, Tawfik O, Oben R, Williamson S, Jewell W, Suzuki T. Kusumoto M, et al. Cancer Immunol Immunother. 2001 Sep;50(7):373-81. doi: 10.1007/s002620100213. Cancer Immunol Immunother. 2001. PMID: 11676397 Free PMC article. Clinical Trial.

2

GM-CSF gene therapy using adenoviral vector in hamster pancreatic cancer.

Ogawa T, Kusumoto M, Mizumoto K, Sato N, Nagai E, Ikubo A, Aoki Y, Tanaka M. Ogawa T, et al. Among authors: kusumoto m. J Hepatobiliary Pancreat Surg. 2000;7(3):306-11. doi: 10.1007/s005340070053. J Hepatobiliary Pancreat Surg. 2000. PMID: 10982631

3

[Adjuvant GM-CSF cytokine gene therapy for breast cancer].

Ogawa T, Kusumoto M, Kuroki S, Nagata S, Yamanaka N, Kawano R, Yoshida J, Shinohara M, Matsuo K. Ogawa T, et al. Among authors: kusumoto m. Gan To Kagaku Ryoho. 2001 Oct;28(11):1512-4. Gan To Kagaku Ryoho. 2001. PMID: 11707967 Japanese.

4

9-Hydroxyellipticine inhibits telomerase activity in human pancreatic cancer cells.

Sato N, Mizumoto K, Kusumoto M, Niiyama H, Maehara N, Ogawa T, Tanaka M. Sato N, et al. Among authors: kusumoto m. FEBS Lett. 1998 Dec 18;441(2):318-21. doi: 10.1016/s0014-5793(98)01571-3. FEBS Lett. 1998. PMID: 9883907 Free article.

5

Adenoviral GM-CSF Gene Transduction into Breast Cancer Cells Induced Long-Lasting Antitumor Immunity in Mice.

Ogawa T, Kusumoto M, Mizumoto K, Sato N, Tanaka M. Ogawa T, et al. Among authors: kusumoto m. Breast Cancer. 1999 Oct 25;6(4):301-304. doi: 10.1007/BF02966444. Breast Cancer. 1999. PMID: 11091734

6

Telomerase activity detected in pancreatic juice 19 months before a tumor is detected in a patient with pancreatic cancer.

Suehara N, Mizumoto K, Kusumoto M, Niiyama H, Ogawa T, Yamaguchi K, Yokohata K, Tanaka M. Suehara N, et al. Among authors: kusumoto m. Am J Gastroenterol. 1998 Oct;93(10):1967-71. doi: 10.1111/j.1572-0241.1998.00557.x. Am J Gastroenterol. 1998. PMID: 9772067

7

Centrosome abnormalities in pancreatic ductal carcinoma.

Sato N, Mizumoto K, Nakamura M, Nakamura K, Kusumoto M, Niiyama H, Ogawa T, Tanaka M. Sato N, et al. Among authors: kusumoto m. Clin Cancer Res. 1999 May;5(5):963-70. Clin Cancer Res. 1999. PMID: 10353727

8

Quantitative determination of apoptotic death in cultured human pancreatic cancer cells by propidium iodide and digitonin.

Zhang L, Mizumoto K, Sato N, Ogawa T, Kusumoto M, Niiyama H, Tanaka M. Zhang L, et al. Among authors: kusumoto m. Cancer Lett. 1999 Aug 3;142(2):129-37. doi: 10.1016/s0304-3835(99)00107-x. Cancer Lett. 1999. PMID: 10463768

9

Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells.

Kusumoto M, Ogawa T, Mizumoto K, Ueno H, Niiyama H, Sato N, Nakamura M, Tanaka M. Kusumoto M, et al. Clin Cancer Res. 1999 Aug;5(8):2140-7. Clin Cancer Res. 1999. PMID: 10473098

10

Diverse effects of 9-hydroxyellipticine on the chemosensitivity of human pancreatic cancer cells harboring p53 mutations.

Mizumoto K, Sato N, Kusumoto M, Niiyama H, Maehara N, Nishio S, Li Z, Ogawa T, Tanaka M. Mizumoto K, et al. Among authors: kusumoto m. Cancer Lett. 2000 Feb 28;149(1-2):85-94. doi: 10.1016/s0304-3835(99)00345-6. Cancer Lett. 2000. PMID: 10737712

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

380 results

Search Page

Filters